Critical role of p38 MAPK in IL-4-induced alternative activation of peritoneal macrophages

European Journal of Immunology

Volumn 45, Issue 1, 2015, Pages 273-286

  Jiménez Garcia, Lidia ^a   Herránz, Sandra ^a   Luque, Alfonso ^a   Hortelano, Sonsoles ^a  

^a Instituto de Salud Carlos III   (Spain)

Author keywords

Alternative activation; Chitin; IL 4; JAK STAT; Macrophages; P38 MAPK

Indexed keywords

CHITIN; INTERLEUKIN 4; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; STAT6 PROTEIN; THIOGLYCOLIC ACID; INTERLEUKIN 4 RECEPTOR; PROTEIN KINASE B; PROTEIN KINASE INHIBITOR; SMALL INTERFERING RNA; STAT6 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ARTICLE; CELL POLARITY; GENE SILENCING; GENETIC TRANSFECTION; MACROPHAGE ACTIVATION; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR BINDING; SIGNAL TRANSDUCTION; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; PHOSPHORYLATION; PRIMARY CELL CULTURE;

ANIMALS; CHITIN; GENE EXPRESSION REGULATION; INTERLEUKIN-4; MACROPHAGE ACTIVATION; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED C57BL; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PRIMARY CELL CULTURE; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, INTERLEUKIN-4; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STAT6 TRANSCRIPTION FACTOR;

EID: 84920944899     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201444806     Document Type: Article

References (53)

1. Martinez, F. O., Sica, A., Mantovani, A. and Locati, M., Macrophage activation and polarization. Front Biosci. 2008. 13: 453-461.
2. Martinez, F. O., Helming, L. and Gordon, S., Alternative activation of macrophages: an immunologic functional perspective. Annu. Rev. Immunol. 2009. 27: 451-483.
3. Gordon, S., Alternative activation of macrophages. Nat. Rev. Immunol. 2003. 3: 23-35.
4. Munder, M., Eichmann, K. and Modolell, M., Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase/arginase balance: competitive regulation by CD4+ T cells correlates with Th1/Th2 phenotype. J. Immunol. 1998. 160: 5347-5354.
5. Raes, G., De Baetselier, P., Noel, W., Beschin, A., Brombacher, F. and Hassanzadeh, G. G., Differential expression of FIZZ1 and Ym1 in alternatively versus classically activated macrophages. J. Leukoc. Biol. 2002. 71: 597-602.
6. Martinez, F. O., Helming, L., Milde, R., Varin, A., Melgert, B. N., Draijer, C., Thomas, B. et al., Genetic programs expressed in resting and IL-4 alternatively activated mouse and human macrophages: similarities and differences. Blood 2013. 121: e57-e69.
7. Pauleau, A. L., Rutschman, R., Lang, R., Pernis, A., Watowich, S. S. and Murray, P. J., Enhancer-mediated control of macrophage-specific arginase I expression. J. Immunol. 2004. 172: 7565-7573.
8. Gray, M. J., Poljakovic, M., Kepka-Lenhart, D. and Morris, J., Induction of arginase I transcription by IL-4 requires a composite DNA response element for STAT6 and C/EBPβ|. Gene 2005. 353: 98-106.
9. Wang, L. M., Myers, M. G., Sun, X. J., Aaronson, S. A., White, M. and Pierce, J. H., IRS-1: essential for insulin- and IL-4-stimulated mitogenesis in hematopoietic cells. Science 1993. 261: 1591-1594.
10. Moore, P. E., Church, T. L., Chism, D. D., Panettieri, R. A., Jr. and Shore, S. A., IL-13 and IL-4 cause eotaxin release in human airway smooth muscle cells: a role for ERK. Am. J. Physiol. Lung Cell Mol. Physiol. 2002. 282: L847-L853.
11. Canfield, S., Lee, Y., Schr+Âder, A. and Rothman, P., Cutting edge: IL-4 induces suppressor of cytokine signaling-3 expression in B cells by a mechanism dependent on activation of p38 MAPK. J. Immunol. 2005. 174: 2494-2498.
12. Chang, C. I., Zoghi, B., Liao, J. C. and Kuo, L., The involvement of tyrosine kinases, cyclic AMP/protein kinase A, and p38 mitogen-activated protein kinase in IL-13-mediated arginase I induction in macrophages: its implications in IL-13-inhibited nitric oxide production. J. Immunol. 2000. 165: 2134-2141.
13. Kristof, A. S., Pacheco-Rodriguez, G., Schremmer, B. and Moss, J., LY303511 (2-piperazinyl-8-phenyl-4H-1-benzopyran-4-one) acts via phosphatidylinositol 3-kinase-independent pathways to inhibit cell proliferation via mammalian target of rapamycin (mTOR)- and non-mTOR-dependent mechanisms. J. Pharmacol. Exp. Ther. 2005. 314: 1134-1143.
14. Gordon, S. and Martinez, F. O., Alternative Activation of Macrophages: Mechanism and Functions. Immunity 2010. 32: 593-604.
15. Kelly-Welch, A. E., Hanson, E. M., Boothby, M. R. and Keegan, A. D., Interleukin-4 and interleukin-13 signaling connections maps. Science 2003. 300: 1527-1528.
16. Hale, K. K., Trollinger, D., Rihanek, M. and Manthey, C. L., Differential expression and activation of p38 mitogen-activated protein kinase alpha, beta, gamma, and delta in inflammatory cell lineages. J. Immunol. 1999. 162: 4246-4252.
17. Byles, V., Covarrubias, A. J., Ben-Sahra, I., Lamming, D. W., Sabatini, D. M., Manning, B. D. and Horng, T., The TSC-mTOR pathway regulates macrophage polarization. Nat. Commun. 2013. 4: 2834.
18. Satoh, T., Takeuchi, O., Vandenbon, A., Yasuda, K., Tanaka, Y., Kumagai, Y., Miyake, T. et al., The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection. Nat. Immunol. 2010. 11: 936-944.
19. Reese, T. A., Liang, H. E., Tager, A. M., Luster, A. D., Van, R. N., Voehringer, D. and Locksley, R. M., Chitin induces accumulation in tissue of innate immune cells associated with allergy. Nature 2007. 447: 92-96.
20. Bowman, S. M. and Free, S. J., The structure and synthesis of the fungal cell wall. Bioessays 2006. 28: 799-808.
21. Heller, N. M., Qi, X., Junttila, I. S., Shirey, K. A., Vogel, S. N., Paul, W. E. and Keegan, A. D., Type I IL-4Rs selectively activate IRS-2 to induce target gene expression in macrophages. Sci. Signal. 2008. 1: ra17.
22. Weisser, S. B., McLarren, K. W., Voglmaier, N., van Netten-Thomas, C. J., Antov, A., Flavell, R. A. and Sly, L. M., Alternative activation of macrophages by IL-4 requires SHIP degradation. Eur. J. Immunol. 2011. 41: 1742-1753.
23. Broadhurst, M. J., Leung, J. M., Lim, K. C., Girgis, N. M., Gundra, U. M., Fallon, P. G., Premenko-Lanier, M. et al., Upregulation of retinal dehydrogenase 2 in alternatively activated macrophages during retinoid-dependent type-2 immunity to helminth infection in mice. PLoS Pathog. 2012. 8: e1002883.
24. Doherty, T. A., Khorram, N., Sugimoto, K., Sheppard, D., Rosenthal, P., Cho, J. Y., Pham, A. et al., Alternaria induces STAT6-dependent acute airway eosinophilia and epithelial FIZZ1 expression that promotes airway fibrosis and epithelial thickness. J. Immunol. 2012. 188: 2622-2629.
25. Gupta, S., Jiang, M., Anthony, A. and Pernis, A. B., Lineage-specific modulation of interleukin 4 signaling by interferon regulatory factor 4. J. Exp. Med. 1999. 190: 1837-1848.
26. Hirst, S. J., Hallsworth, M. P., Peng, Q. and Lee, T. H., Selective induction of eotaxin release by interleukin-13 or interleukin-4 in human airway smooth muscle cells is synergistic with interleukin-1beta and is mediated by the interleukin-4 receptor alpha-chain. Am. J. Respir. Crit. Care Med. 2002. 165: 1161-1171.
27. Hunt, A. E., Williams, L. M., Lali, F. V. and Foxwell, B. M., IL-4 regulation of p38 MAPK signalling is dependent on cell type. Cytokine 2002. 18: 295-303.
28. Pesu, M., Aittomaki, S., Takaluoma, K., Lagerstedt, A. and Silvennoinen, O., p38 Mitogen-activated protein kinase regulates interleukin-4-induced gene expression by stimulating STAT6-mediated transcription. J. Biol. Chem. 2002. 277: 38254-38261.
29. Wery-Zennaro, S., Zugaza, J. L., Letourneur, M., Bertoglio, J. and Pierre, J., IL-4 regulation of IL-6 production involves Rac/Cdc42- and p38 MAPK-dependent pathways in keratinocytes. Oncogene 2000. 19: 1596-1604.
30. Reibman, J., Hsu, Y., Chen, L. C., Bleck, B. and Gordon, T., Airway epithelial cells release MIP-3alpha/CCL20 in response to cytokines and ambient particulate matter. Am. J. Respir. Cell Mol. Biol. 2003. 28: 648-654.
31. Ihn, H., Yamane, K., Asano, Y., Kubo, M. and Tamaki, K., IL-4 up-regulates the expression of tissue inhibitor of metalloproteinase-2 in dermal fibroblasts via the p38 mitogen-activated protein kinase-dependent pathway. J. Immunol. 2002. 168: 1895-1902.
32. Kim, H. D., Yu, S. J., Kim, H. S., Kim, Y. J., Choe, J. M., Park, Y. G., Kim, J. and Sohn, J., Interleukin-4 induces senescence in human renal carcinoma cell lines through STAT6 and p38 MAPK. J. Biol. Chem. 2013. 288: 28743-28754.
33. Jin, C., Wu, L., Li, J., Fang, M., Cheng, L. and Wu, N., Multiple signaling pathways are involved in the interleukine-4 regulated expression of DC-SIGN in THP-1 cell line. J. Biomed. Biotechnol. 2012. 2012: 357060.
34. Csoka, B., Selmeczy, Z., Koscso, B., Nemeth, Z. H., Pacher, P., Murray, P. J., Kepka-Lenhart, D. et al., Adenosine promotes alternative macrophage activation via A2A and A2B receptors. FASEB J. 2012. 26: 376-386.
35. Shao, Q., Ning, H., Lv, J., Liu, Y., Zhao, X., Ren, G., Feng, A. et al., Regulation of Th1/Th2 polarization by tissue inhibitor of metalloproteinase-3 via modulating dendritic cells. Blood 2012. 119: 4636-4644.
36. Jang, Y. S., Kim, H. A., Park, S. R., Lee, M. R., Park, J. B. and Kim, P. H., IL-4 stimulates mouse macrophages to express APRIL through p38 MAPK and two different downstream molecules, CREB and Stat6. Cytokine 2009. 47: 43-47.
37. Escolano, A., Martinez-Martinez, S., Alfranca, A., Urso, K., Izquierdo, H. M., Delgado, M., Martin, F. et al., Specific calcineurin targeting in macrophages confers resistance to inflammation via MKP-1 and p38. EMBO J. 2014 33: 1117-1133.
38. Tsubaki, M., Kato, C., Isono, A., Kaneko, J., Isozaki, M., Satou, T., Itoh, T. et al., Macrophage inflammatory protein-1alpha induces osteoclast formation by activation of the MEK/ERK/c-Fos pathway and inhibition of the p38 MAPK/IRF-3/IFN-beta pathway. J. Cell Biochem. 2010. 111: 1661-1672.
39. Alam, M. S., Gaida, M. M., Ogawa, Y., Kolios, A. G., Lasitschka, F. and Ashwell, J. D., Counter-regulation of T cell effector function by differentially activated p38. J. Exp. Med. 2014. 211: 1257-1270.
40. Rauh, M. J., Ho, V., Pereira, C., Sham, A., Sly, L. M., Lam, V., Huxham, L. et al., SHIP represses the generation of alternatively activated macrophages. Immunity 2005. 23: 361-374.
41. Bhattacharjee, A., Pal, S., Feldman, G. M. and Cathcart, M. K., Hck is a key regulator of gene expression in alternatively activated human monocytes. J. Biol. Chem. 2011. 286: 36709-36723.
42. Xu, B., Bhattacharjee, A., Roy, B., Xu, H. M., Anthony, D., Frank, D. A., Feldman, G. M. and Cathcart, M. K., Interleukin-13 induction of 15-lipoxygenase gene expression requires p38 mitogen-activated protein kinase-mediated serine 727 phosphorylation of Stat1 and Stat3. Mol. Cell Biol. 2003. 23: 3918-3928.
43. Cuadrado, A. and Nebreda, A. R., Mechanisms and functions of p38 MAPK signalling. Biochem. J. 2010. 429: 403-417.
44. Seimon, T. A., Wang, Y., Han, S., Senokuchi, T., Schrijvers, D. M., Kuriakose, G., Tall, A. R. and Tabas, I. A., Macrophage deficiency of p38+| MAPK promotes apoptosis and plaque necrosis in advanced atherosclerotic lesions in mice. J. Clin. Invest. 2009. 119: 886-898.
45. Wu, R., Kausar, H., Johnson, P., Montoya-Durango, D. E., Merchant, M. and Rane, M. J., Hsp27 regulates Akt activation and polymorphonuclear leukocyte apoptosis by scaffolding MK2 to Akt signal complex. J. Biol. Chem. 2007. 282: 21598-21608.
46. Zheng, C., Lin, Z., Zhao, Z. J., Yang, Y., Niu, H. and Shen, X., MAPK-activated protein kinase-2 (MK2)-mediated formation and phosphorylation-regulated dissociation of the signal complex consisting of p38, MK2, Akt, and Hsp27. J. Biol. Chem. 2006. 281: 37215-37226.
47. Taniyama, Y., Ushio-Fukai, M., Hitomi, H., Rocic, P., Kingsley, M. J., Pfahnl, C., Weber, D. S. et al., Role of p38 MAPK and MAPKAPK-2 in angiotensin II-induced Akt activation in vascular smooth muscle cells. Am. J. Physiol. Cell Physiol. 2004. 287: C494-C499.
48. Boorsma, C. E., Draijer, C. and Melgert, B. N., Macrophage heterogeneity in respiratory diseases. Mediators. Inflamm. 2013. 2013: 769214.
49. Bhavsar, P., Hew, M., Khorasani, N., Torrego, A., Barnes, P. J., Adcock, I. and Chung, K. F., Relative corticosteroid insensitivity of alveolar macrophages in severe asthma compared with non-severe asthma. Thorax 2008. 63: 784-790.
50. Huang, C., Xie, M., He, X. and Gao, H., Activity of sputum p38 MAPK is correlated with airway inflammation and reduced FEV1 in COPD patients. Med. Sci. Monit. 2013. 19: 1229-1235.
51. Zeini, M., Traves, P. G., Lopez-Fontal, R., Pantoja, C., Matheu, A., Serrano, M., Bosca, L. and Hortelano, S., Specific contribution of p19(ARF) to nitric oxide-dependent apoptosis. J. Immunol. 2006. 177: 3327-3336.
52. Herranz, S., Traves, P. G., Luque, A. and Hortelano, S., Role of the tumor suppressor ARF in macrophage polarization: Enhancement of the M2 phenotype in ARF-deficient mice. Oncoimmunology 2012. 1: 1227-1238.
53. Traves, P. G., Lopez-Fontal, R., Luque, A. and Hortelano, S., The tumor suppressor ARF regulates innate immune responses in mice. J. Immunol. 2011. 187: 6527-6538.